{"id":"azithromycin-az","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-5","effect":"Nausea"},{"rate":"2-5","effect":"Abdominal pain"},{"rate":"1-3","effect":"Vomiting"},{"rate":"rare","effect":"QT prolongation"},{"rate":"rare","effect":"Hepatotoxicity"},{"rate":"rare","effect":"Clostridium difficile-associated diarrhea"}]},"_chembl":{"chemblId":"CHEMBL4526902","moleculeType":"Unknown"},"_dailymed":{"setId":"24c07398-84ad-48e2-9625-e9073c28fb73","title":"AZITHROMYCIN TABLET, FILM COATED [A-S MEDICATION SOLUTIONS]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin is a macrolide antibiotic that binds irreversibly to the bacterial 50S ribosomal subunit, blocking the translocation of peptides and inhibiting protein synthesis. This bacteriostatic action prevents bacterial replication and allows the immune system to clear the infection. It has broad-spectrum activity against many gram-positive and gram-negative bacteria, as well as atypical organisms.","oneSentence":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and stopping bacterial growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:30:27.339Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Acute otitis media"},{"name":"Pharyngitis/tonsillitis"},{"name":"Uncomplicated skin and soft tissue infections"},{"name":"Sexually transmitted infections (chlamydia, gonorrhea)"},{"name":"Mycobacterium avium complex (MAC) prophylaxis in HIV patients"}]},"trialDetails":[{"nctId":"NCT07052942","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care (Full Study)","status":"RECRUITING","sponsor":"DARTNet Institute","startDate":"2025-08-01","conditions":"Asthma, Asthma Attack, Asthma Exacerbations","enrollment":3200},{"nctId":"NCT04669288","phase":"PHASE3","title":"AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department","status":"TERMINATED","sponsor":"University of Arizona","startDate":"2021-09-22","conditions":"Asthma, Wheezing","enrollment":840},{"nctId":"NCT05506371","phase":"NA","title":"Effects of Azithromycin as an Adjunct to Scaling and Root Planning in the Treatment of Periodontitis","status":"COMPLETED","sponsor":"Ukrainian Medical Stomatological Academy","startDate":"2017-09-16","conditions":"Periodontitis","enrollment":50},{"nctId":"NCT03208179","phase":"PHASE3","title":"Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa","status":"COMPLETED","sponsor":"Liverpool School of Tropical Medicine","startDate":"2018-03-29","conditions":"Pregnancy, Malaria in Pregnancy, Malaria","enrollment":4680},{"nctId":"NCT04374903","phase":"NA","title":"Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2022-04-01","conditions":"COVID-19 Patients","enrollment":""},{"nctId":"NCT00000811","phase":"PHASE2","title":"A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Bacterial Infections, Pneumonia, Pneumocystis Carinii, HIV Infections","enrollment":690},{"nctId":"NCT04354597","phase":"NA","title":"Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients","status":"WITHDRAWN","sponsor":"King Hussein Cancer Center","startDate":"2020-05-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT03278808","phase":"PHASE2","title":"Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis","status":"WITHDRAWN","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2018-09-17","conditions":"Malaria","enrollment":""},{"nctId":"NCT03944317","phase":"NA","title":"Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)","status":"UNKNOWN","sponsor":"Federal Medical Centre, Owo","startDate":"2019-06-01","conditions":"Malaria in Pregnancy, Pregnancy","enrollment":168},{"nctId":"NCT03535558","phase":"","title":"Fluoroquinolone Associated Disability","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-17","conditions":"Bronchitis, Sinusitis, Urinary Tract Infections","enrollment":239306},{"nctId":"NCT02211729","phase":"PHASE3","title":"A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2014-05","conditions":"Malaria, Respiratory Infections","enrollment":22090},{"nctId":"NCT02115516","phase":"PHASE1","title":"Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2014-04","conditions":"Malaria, Plasmodium Falciparum Malaria","enrollment":67},{"nctId":"NCT01103713","phase":"PHASE3","title":"Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa","status":"TERMINATED","sponsor":"Pfizer","startDate":"2011-03","conditions":"Asymptomatic Parasitemia In Pregnancy","enrollment":168},{"nctId":"NCT02126267","phase":"NA","title":"Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection","status":"COMPLETED","sponsor":"Centro Universitario de Lavras","startDate":"2013-01","conditions":"Periodontal Disease, Chronic Periodontitis","enrollment":77},{"nctId":"NCT01100060","phase":"PHASE1","title":"A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-04","conditions":"Malaria Prophylaxis","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zithromax"],"phase":"marketed","status":"active","brandName":"azithromycin (AZ)","genericName":"azithromycin (AZ)","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and stopping bacterial growth. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Acute otitis media.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}